Published in J Exp Med on December 21, 1998
A role for NKG2D in NK cell-mediated resistance to poxvirus disease. PLoS Pathog (2008) 1.72
Requirement for membrane lymphotoxin in natural killer cell development. Proc Natl Acad Sci U S A (1999) 1.27
The natural killer complex regulates severe malarial pathogenesis and influences acquired immune responses to Plasmodium berghei ANKA. Infect Immun (2005) 1.07
The natural killer gene complex genetic locus Chok encodes Ly-49D, a target recognition receptor that activates natural killing. Proc Natl Acad Sci U S A (1999) 1.05
Ligand dimensions are important in controlling NK-cell responses. Eur J Immunol (2010) 0.87
Murine trophoblast cells induce NK cell interferon-gamma production through KLRK1. Biol Reprod (2010) 0.78
Genetic dissection of NK cell responses. Front Immunol (2013) 0.77
Deficiency of the adaptor protein SLy1 results in a natural killer cell ribosomopathy affecting tumor clearance. Oncoimmunology (2016) 0.75
Biology of natural killer cells. Adv Immunol (1989) 14.77
Cytotoxicity mediated by T cells and natural killer cells is greatly impaired in perforin-deficient mice. Nature (1994) 11.22
In search of the 'missing self': MHC molecules and NK cell recognition. Immunol Today (1990) 10.84
Selective rejection of H-2-deficient lymphoma variants suggests alternative immune defence strategy. Nature (1986) 9.73
Fc receptors. Annu Rev Immunol (1991) 7.92
"Natural" killer cells in the mouse. I. Cytotoxic cells with specificity for mouse Moloney leukemia cells. Specificity and distribution according to genotype. Eur J Immunol (1975) 7.61
Natural cytotoxic reactivity of mouse lymphoid cells against syngeneic acid allogeneic tumors. I. Distribution of reactivity and specificity. Int J Cancer (1975) 5.91
MHC class I alloantigen specificity of Ly-49+ IL-2-activated natural killer cells. Nature (1992) 5.04
Dissection of the lymphokine-activated killer phenomenon. Relative contribution of peripheral blood natural killer cells and T lymphocytes to cytolysis. J Exp Med (1986) 3.99
Recruitment of tyrosine phosphatase HCP by the killer cell inhibitor receptor. Immunity (1996) 3.33
The Ly-49 and NKR-P1 gene families encoding lectin-like receptors on natural killer cells: the NK gene complex. Annu Rev Immunol (1993) 3.01
Cmv-1, a genetic locus that controls murine cytomegalovirus replication in the spleen. J Exp Med (1990) 2.55
Natural killer cells: definition of a cell type rather than a function. J Immunol (1986) 2.46
The role of natural killer cells in innate resistance to infection. Curr Opin Immunol (1993) 2.42
Monoclonal antibody to a triggering structure expressed on rat natural killer cells and adherent lymphokine-activated killer cells. J Exp Med (1989) 2.33
The effect of the Cmv-1 resistance gene, which is linked to the natural killer cell gene complex, is mediated by natural killer cells. J Immunol (1992) 2.08
Ly-49D and Ly-49H associate with mouse DAP12 and form activating receptors. J Immunol (1998) 2.06
Interleukin 2 activation of natural killer cells rapidly induces the expression and phosphorylation of the Leu-23 activation antigen. J Exp Med (1988) 1.95
The binding and lysis of target cells by cytotoxic lymphocytes: molecular and cellular aspects. Annu Rev Immunol (1994) 1.93
Human and mouse killer-cell inhibitory receptors recruit PTP1C and PTP1D protein tyrosine phosphatases. J Immunol (1996) 1.90
Cloning and characterization of the 2B4 gene encoding a molecule associated with non-MHC-restricted killing mediated by activated natural killer cells and T cells. J Immunol (1993) 1.87
cDNA cloning of mouse NKR-P1 and genetic linkage with LY-49. Identification of a natural killer cell gene complex on mouse chromosome 6. J Immunol (1991) 1.82
Chromosomal location of the Ly-49 (A1, YE1/48) multigene family. Genetic association with the NK 1.1 antigen. J Immunol (1990) 1.74
Major histocompatibility complex class I-dependent skewing of the natural killer cell Ly49 receptor repertoire. Eur J Immunol (1996) 1.67
A novel function-associated molecule related to non-MHC-restricted cytotoxicity mediated by activated natural killer cells and T cells. J Immunol (1993) 1.61
Stimulation of murine natural killer (NK) cells by a monoclonal antibody specific for the NK1.1 antigen. IL-2-activated NK cells possess additional specific stimulation pathways. J Immunol (1991) 1.52
YAC-1 MHC class I variants reveal an association between decreased NK sensitivity and increased H-2 expression after interferon treatment or in vivo passage. J Immunol (1985) 1.51
Phosphotyrosines in the killer cell inhibitory receptor motif of NKB1 are required for negative signaling and for association with protein tyrosine phosphatase 1C. J Exp Med (1996) 1.50
A natural killer cell receptor specific for a major histocompatibility complex class I molecule. J Exp Med (1994) 1.48
Natural killer cells wear different hats: effector cells of innate resistance and regulatory cells of adaptive immunity and of hematopoiesis. Semin Immunol (1995) 1.47
Expression of different members of the Ly-49 gene family defines distinct natural killer cell subsets and cell adhesion properties. J Exp Med (1994) 1.46
Molecular characterization of human CD94: a type II membrane glycoprotein related to the C-type lectin superfamily. Eur J Immunol (1995) 1.40
The Ly-49D receptor activates murine natural killer cells. J Exp Med (1996) 1.39
Mouse Ly-49A interrupts early signaling events in natural killer cell cytotoxicity and functionally associates with the SHP-1 tyrosine phosphatase. J Exp Med (1997) 1.37
Cloning and functional characteristics of murine large granular lymphocyte-1: a member of the Ly-49 gene family (Ly-49G2) J Exp Med (1995) 1.35
Cloning of a mouse homolog of CD94 extends the family of C-type lectins on murine natural killer cells. Eur J Immunol (1997) 1.27
Host MHC class I molecules modulate in vivo expression of a NK cell receptor. J Immunol (1994) 1.25
Recognition structures on natural killer cells. Curr Opin Immunol (1993) 1.24
Altered phenotype and function of natural killer cells expressing the major histocompatibility complex receptor Ly-49 in mice transgenic for its ligand. Proc Natl Acad Sci U S A (1995) 1.22
Perforin, Fas ligand, and tumor necrosis factor are the major cytotoxic molecules used by lymphokine-activated killer cells. J Immunol (1996) 1.20
Transcriptional regulation of the gene encoding the human C-type lectin leukocyte receptor AIM/CD69 and functional characterization of its tumor necrosis factor-alpha-responsive elements. J Biol Chem (1995) 1.19
Generation and characterization of purified adherent lymphokine-activated killer cells in mice. J Immunol (1989) 1.19
Hematopoietic cells and radioresistant host elements influence natural killer cell differentiation. J Exp Med (1993) 1.18
Murine Nkg2d and Cd94 are clustered within the natural killer complex and are expressed independently in natural killer cells. Proc Natl Acad Sci U S A (1998) 1.18
NKR-P1A is a target-specific receptor that activates natural killer cell cytotoxicity. J Exp Med (1995) 1.18
Development of intra-natural killer complex (NKC) recombinant and congenic mouse strains for mapping and functional analysis of NK cell regulatory loci. Immunogenetics (1999) 1.14
A 2-Mb YAC contig and physical map of the natural killer gene complex on mouse chromosome 6. Genomics (1997) 1.13
A multigene family on human chromosome 12 encodes natural killer-cell lectins. Immunogenetics (1993) 1.12
Genomic structure and strain-specific expression of the natural killer cell receptor NKR-P1. J Immunol (1992) 1.11
An autosomal dominant locus, Nka, mapping to the Ly-49 region of a rat natural killer (NK) gene complex, controls NK cell lysis of allogeneic lymphocytes. J Exp Med (1996) 1.11
Cloning and characterization of 5E6(Ly-49C), a receptor molecule expressed on a subset of murine natural killer cells. J Exp Med (1995) 1.11
The BALB.B6-Cmv1r mouse: a strain congenic for Cmv1 and the NK gene complex. Immunogenetics (1995) 1.07
Characterization of an associated 16-kDa tyrosine phosphoprotein required for Ly-49D signal transduction. J Immunol (1998) 1.06
Molecular characterization of a gene in the rat homologous to human CD94. Eur J Immunol (1997) 1.01
Prp (proline-rich protein) genes linked to markers Es-12 (esterase-12), Ea-10 (erythrocyte alloantigen), and loci on distal mouse chromosome 6. Genomics (1989) 0.99
Major histocompatibility complex genes determine natural killer cell tolerance. Eur J Immunol (1996) 0.96
Specific engagement of the CD94/NKG2-A killer inhibitory receptor by the HLA-E class Ib molecule induces SHP-1 phosphatase recruitment to tyrosine-phosphorylated NKG2-A: evidence for receptor function in heterologous transfectants. Eur J Immunol (1998) 0.96
T cell independence of macrophage and natural killer cell infiltration, cytokine production, and endothelial activation during delayed xenograft rejection. Transplantation (1996) 0.95
Genomic structure, chromosome location, and alternative splicing of the human NKG2A gene. Immunogenetics (1996) 0.94
Direct activation of porcine endothelial cells by human natural killer cells. Transplantation (1996) 0.92
High level, stable production of recombinant proteins in mammalian cell culture using the herpesvirus VP16 transactivator. Biotechnology (N Y) (1993) 0.91
Ly-49-independent natural killer (NK) cell specificity revealed by NK cell clones derived from p53-deficient mice. J Exp Med (1995) 0.90
Missing self recognition by natural killer cells in MHC class I transgenic mice. A 'receptor calibration' model for how effector cells adapt to self. Semin Immunol (1995) 0.90
The role of asparagine-linked carbohydrate in natural killer cell-mediated cytolysis. J Biol Chem (1987) 0.90
Xenotransplantation. Annu Rev Immunol (1995) 0.89
Differential tyrosine phosphorylation of inhibitory versus activating Ly-49 receptor proteins and their recruitment of SHP-1 phosphatase. J Immunol (1997) 0.89
Natural killer cells generated from bone marrow culture. J Immunol (1984) 0.89
Natural killer cell- and macrophage-mediated rejection of concordant xenografts in the absence of T and B cell responses. J Immunol (1997) 0.88
"Xenogeneic resistance" to rat bone marrow transplantation. I. The basic phenomenon. Proc Soc Exp Biol Med (1973) 0.84
Biochemical characterization of animal cell glycosylation mutants. Methods Enzymol (1987) 0.84
Genetic resistance to marrow transplantation. Biomedicine (1973) 0.78
Role of target cell glycoproteins in sensitivity to natural killer cell lysis. J Biol Chem (1993) 0.77
Natural killer cells discriminate between high mannose- and complex-type asparagine-linked oligosaccharides. Biochimie (1988) 0.76
Apparent identity of mechanisms of genetic resistance to marrow transplantation and natural killer cell activity. Biomedicine (1979) 0.76
Genetic control of bone marrow transplantation in irradiated mice: classification of mouse strains according to their responsiveness to bone marrow allografts and xenografts. Transplant Proc (1977) 0.76
MHC class I alloantigen specificity of Ly-49+ IL-2-activated natural killer cells. Nature (1992) 5.04
Clonal distribution of resistance plasmid-carrying Salmonella typhimurium, mainly in the Middle East. J Hyg (Lond) (1977) 4.46
Heterogeneity of Escherichia coli phages encoding Vero cytotoxins: comparison of cloned sequences determining VT1 and VT2 and development of specific gene probes. J Gen Microbiol (1987) 4.35
Vital involvement of a natural killer cell activation receptor in resistance to viral infection. Science (2001) 4.18
Specific and nonspecific NK cell activation during virus infection. Nat Immunol (2001) 4.02
Haemorrhagic colitis and Vero-cytotoxin-producing Escherichia coli in England and Wales. Lancet (1987) 3.79
Chloramphenicol resistance in the typhoid bacillus. Br Med J (1972) 3.79
Ciprofloxacin-resistant Salmonella typhi and treatment failure. Lancet (1999) 3.78
A study of infectious intestinal disease in England: microbiological findings in cases and controls. Commun Dis Public Health (1999) 3.72
Cloning of genes determining the production of vero cytotoxin by Escherichia coli. J Gen Microbiol (1985) 3.60
Haemolytic uraemic syndromes in the British Isles, 1985-8: association with verocytotoxin producing Escherichia coli. Part 2: Microbiological aspects. Arch Dis Child (1990) 3.51
Vero cytotoxin-producing strains of Escherichia coli from children with haemolytic uraemic syndrome and their detection by specific DNA probes. J Med Microbiol (1988) 3.25
Molecular studies of an fi+ plasmid from strains of Salmonella typhimurium. Mol Gen Genet (1973) 3.05
Application of agarose gel electrophoresis to the characterization of plasmid DNA in drug-resistant enterobacteria. J Gen Microbiol (1979) 3.02
Properties of strains of Escherichia coli belonging to serogroup O157 with special reference to production of Vero cytotoxins VT1 and VT2. Epidemiol Infect (1987) 2.98
Mutagenesis of plasmid DNA with hydroxylamine: isolation of mutants of multi-copy plasmids. Mol Gen Genet (1976) 2.92
Serological identification of Escherichia coli O157:H7 infection in haemolytic uraemic syndrome. Lancet (1991) 2.80
In vivo natural killer cell activities revealed by natural killer cell-deficient mice. Proc Natl Acad Sci U S A (2000) 2.76
Inhibition of natural killer cells by a cytomegalovirus MHC class I homologue in vivo. Nature (1997) 2.63
Two distinct toxins active on Vero cells from Escherichia coli O157. Lancet (1985) 2.47
Screening for enteropathogenic Escherichia coli in infants with diarrhea by the fluorescent-actin staining test. Infect Immun (1991) 2.35
Properties of Vero cytotoxin-producing Escherichia coli of human origin of O serogroups other than O157. J Infect Dis (1992) 2.23
Genetic and molecular characterisation of some non-transferring plasmids. Mol Gen Genet (1974) 2.16
Identification of a T3-associated gamma delta T cell receptor on Thy-1+ dendritic epidermal Cell lines. Science (1987) 2.12
Cocaine-related vasculitis causing upper-limb peripheral vascular disease. Ann Intern Med (2000) 2.01
CD47 (integrin-associated protein) engagement of dendritic cell and macrophage counterreceptors is required to prevent the clearance of donor lymphohematopoietic cells. J Exp Med (2001) 1.99
Aerosolized antigen exposure without adjuvant causes increased IgE production and increased airway responsiveness in the mouse. J Allergy Clin Immunol (1992) 1.95
CD1d-restricted NKT cells: an interstrain comparison. J Immunol (2001) 1.88
Role of guanine nucleotide-binding proteins--ras-family or trimeric proteins or both--in Ca2+ sensitization of smooth muscle. Proc Natl Acad Sci U S A (1996) 1.87
Non-radioactively labelled polynucleotide and oligonucleotide DNA probes, for selectively detecting Escherichia coli strains producing Vero cytotoxins VT1, VT2 and VT2 variant. Mol Cell Probes (1991) 1.86
Interactions of group H resistance factors with the F factor. J Bacteriol (1973) 1.85
Properties of strains of Escherichia coli O26:H11 in relation to their enteropathogenic or enterohemorrhagic classification. J Infect Dis (1990) 1.84
Perforin is a major contributor to NK cell control of tumor metastasis. J Immunol (1999) 1.83
cDNA cloning of mouse NKR-P1 and genetic linkage with LY-49. Identification of a natural killer cell gene complex on mouse chromosome 6. J Immunol (1991) 1.82
Vero cytotoxin-producing Escherichia coli, particularly serogroup O 157, associated with human infections in the United Kingdom: 1989-91. Epidemiol Infect (1993) 1.78
Genetic mapping of Cmv1 in the region of mouse chromosome 6 encoding the NK gene complex-associated loci Ly49 and musNKR-P1. Genomics (1995) 1.76
Purification and characterization of the mammalian myosin light chain phosphatase holoenzyme. The differential effects of the holoenzyme and its subunits on smooth muscle. J Biol Chem (1994) 1.76
Vero cytotoxin-producing Escherichia coli O157 outbreaks in England and Wales, 1995: phenotypic methods and genotypic subtyping. Emerg Infect Dis (1997) 1.75
Molecular comparison of plasmids encoding heat-labile enterotoxin isolated from Escherichia coli strains of human origin. J Bacteriol (1980) 1.75
Identification of enteropathogenic Escherichia coli isolated in Britain as enteroaggregative or as members of a subclass of attaching-and-effacing E. coli not hybridising with the EPEC adherence-factor probe. J Med Microbiol (1991) 1.73
Ability of enteroaggregative Escherichia coli strains to adhere in vitro to human intestinal mucosa. Infect Immun (1992) 1.73
Vero cytotoxin production in strain of Escherichia coli is determined by genes carried on bacteriophage. Lancet (1983) 1.73
Mapping of a plasmid, coding for colonization, factor antigen I and heat-stable enterotoxin production, isolated from an enterotoxigenic strain of Escherichia coli. J Bacteriol (1982) 1.73
Fertility inhibition in strains of Salmonella typhimurium. Mol Gen Genet (1972) 1.69
Plasmids coding for colonization factor antigen I and heat-stable enterotoxin production isolated from enterotoxigenic Escherichia coli: comparison of their properties. Infect Immun (1981) 1.68
Genetic control and properties of coli surface antigens of colonization factor antigen IV (PCF8775) of enterotoxigenic Escherichia coli. Infect Immun (1988) 1.67
First recognized community outbreak of haemorrhagic colitis due to verotoxin-producing Escherichia coli O 157.H7 in the UK. Epidemiol Infect (1988) 1.66
Nonstochastic coexpression of activation receptors on murine natural killer cells. J Exp Med (2000) 1.65
Expression of CFA/I fimbriae is positively regulated. Microb Pathog (1990) 1.65
Autoimmunity--a perspective. Annu Rev Immunol (1983) 1.62
Will pharmacogenetics allow better prediction of methotrexate toxicity and efficacy in patients with rheumatoid arthritis? Ann Rheum Dis (2003) 1.59
Progression of changes in dopamine transporter binding site density as a result of cocaine self-administration in rhesus monkeys. J Neurosci (2001) 1.57
Hybridization of strains of Escherichia coli O157 with probes derived from the eaeA gene of enteropathogenic E. coli and the eaeA homolog from a Vero cytotoxin-producing strain of E. coli O157. J Clin Microbiol (1994) 1.57
The use of sorbitol-MacConkey agar in conjunction with a specific antiserum for the detection of Vero cytotoxin-producing strains of Escherichia coli O 157. Epidemiol Infect (1988) 1.54
Expression of plasmids coding for colonization factor antigen II (CFA/II) and enterotoxin production in Escherichia coli. J Gen Microbiol (1983) 1.53
The value of plasmid studies in the epidemiology of infections due to drug-resistant Salmonella wien. J Infect Dis (1979) 1.52
Stimulation of murine natural killer (NK) cells by a monoclonal antibody specific for the NK1.1 antigen. IL-2-activated NK cells possess additional specific stimulation pathways. J Immunol (1991) 1.52
Phage-typing of Vero-cytotoxin (VT) producing Escherichia coli O157 isolated in the United Kingdom. Epidemiol Infect (1989) 1.50
Use of digoxigenin-labelled oligonucleotide DNA probes for VT2 and VT2 human variant genes to differentiate Vero cytotoxin-producing Escherichia coli strains of serogroup O157. J Clin Microbiol (1993) 1.48
Thy-1+ dendritic epidermal cells express T3 antigen and the T-cell receptor gamma chain. Proc Natl Acad Sci U S A (1987) 1.48
A natural killer cell receptor specific for a major histocompatibility complex class I molecule. J Exp Med (1994) 1.48
Ly-49 multigene family expressed by IL-2-activated NK cells. J Immunol (1994) 1.47
Thy-1+ dendritic epidermal cells belong to the T-cell lineage. Proc Natl Acad Sci U S A (1987) 1.46
Plasmids that code for production of colonization factor antigen II and enterotoxin production in strains of Escherichia coli. Infect Immun (1983) 1.46
Requirement for type 2 NO synthase for IL-12 signaling in innate immunity. Science (1999) 1.46
Phage-determined production of vero cytotoxin in strains of Escherichia coli serogroup O157. Lancet (1984) 1.46
Comparison of Vero-cytotoxin-encoding phages from Escherichia coli of human and bovine origin. J Gen Microbiol (1989) 1.45
Thy-1-mediated T-cell activation requires co-expression of CD3/Ti complex. Nature (1987) 1.41
The Ly-49D receptor activates murine natural killer cells. J Exp Med (1996) 1.39
Strains of Escherichia coli belonging to serogroups O157 and O55 express lipopolysaccharides that are structurally distinct and do not share common epitopes. J Infect Dis (1998) 1.39
The inhibitory effect of a selective alpha 2-adrenergic receptor antagonist on moderate- to severe-type asthma. J Allergy Clin Immunol (1989) 1.39
Targeted ablation of the murine alpha-tropomyosin gene. Circ Res (1997) 1.38
CS-A therapy in MRL-lpr/lpr mice: amelioration of immunopathology despite autoantibody production. J Immunol (1987) 1.38
Glove-related hand urticaria in the absence of Type I latex allergy. Contact Dermatitis (1999) 1.38
Plasmids coding for heat-labile enterotoxin production isolated from Escherichia coli O78: comparison of properties. J Bacteriol (1980) 1.37
Verocytotoxin-producing Escherichia coli (VTEC) O157 and other VTEC from human infections in England and Wales: 1995-1998. J Med Microbiol (2001) 1.36
Molecular cloning of the NK1.1 antigen, a member of the NKR-P1 family of natural killer cell activation molecules. J Immunol (1992) 1.36
Vero cytotoxin-producing Escherichia coli, particularly serogroup O157, associated with human infections in England and Wales: 1992-4. Epidemiol Infect (1996) 1.35
Cellular mechanisms involved in protection and recovery from influenza virus infection in immunodeficient mice. J Virol (1996) 1.34
Subtyping of virulence genes in verocytotoxin-producing Escherichia coli (VTEC) other than serogroup O157 associated with disease in the United Kingdom. J Med Microbiol (2003) 1.31
Contribution of small GTPase Rho and its target protein rock in a murine model of lung fibrosis. Am J Respir Crit Care Med (2001) 1.27
Requirement for membrane lymphotoxin in natural killer cell development. Proc Natl Acad Sci U S A (1999) 1.27
Autoimmunity and increased c-myb transcription. Science (1984) 1.27
Airways inflammation in nocturnal asthma. Am Rev Respir Dis (1991) 1.26
Examination of raw beef products for the presence of Vero cytotoxin producing Escherichia coli, particularly those of serogroup O157. J Appl Bacteriol (1993) 1.26
Why do cultured transplanted myoblasts die in vivo? DNA quantification shows enhanced survival of donor male myoblasts in host mice depleted of CD4+ and CD8+ cells or Nk1.1+ cells. Cell Transplant (2001) 1.26
Relaxation of contracted rabbit tracheal and human bronchial smooth muscle by Y-27632 through inhibition of Ca2+ sensitization. Am J Respir Cell Mol Biol (1999) 1.25
Host MHC class I molecules modulate in vivo expression of a NK cell receptor. J Immunol (1994) 1.25
An alpha-cardiac myosin heavy chain gene mutation impairs contraction and relaxation function of cardiac myocytes. Am J Physiol (1999) 1.24
Temporal shedding patterns and virulence factors of Escherichia coli serogroups O26, O103, O111, O145, and O157 in a cohort of beef calves and their dams. Appl Environ Microbiol (2004) 1.24
Properties of Vero cytotoxin-producing Escherichia coli of human and animal origin belonging to serotypes other than O157:H7. Epidemiol Infect (1989) 1.23
Enteroaggregative Escherichia coll and outbreaks of gastroenteritis in UK. Lancet (1997) 1.23
Relationship between mitogenic activity of influenza viruses and the receptor-binding specificity of their hemagglutinin molecules. J Virol (1986) 1.23
Analysis of in situ NK cell responses during viral infection. J Immunol (2001) 1.22